Trials / Completed
CompletedNCT01917682
Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions
A Post-Market Registry for the Evaluation of the CorPath 200 System Effectiveness in Percutaneous Coronary Interventions
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 754 (actual)
- Sponsor
- Corindus Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To collect data on the routine patterns of use, safety and effectiveness, including the clinical and technical performance of the CorPath 200 System, in the delivery and manipulation of coronary guidewires and stent/balloon catheters during PCI procedures.
Detailed description
This is a prospective, single-arm, open-label, multi-center patient registry of the CorPath 200 System to examine its performance during PCI procedure and patient outcomes through 72 hours post-procedure or hospital discharge, whichever occurs first.
Conditions
- Coronary Artery Disease
- Coronary Disease
- Myocardial Ischemia
- Heart Diseases
- Cardiovascular Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Vascular Diseases
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | CorPath-assisted Percutaneous Coronary Intervention | Robotic-assisted Percutaneous Coronary Intervention |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2013-08-07
- Last updated
- 2020-12-22
- Results posted
- 2020-12-02
Locations
16 sites across 2 countries: United States, Israel
Source: ClinicalTrials.gov record NCT01917682. Inclusion in this directory is not an endorsement.